Administration, Intravesical
-
Subject Areas on Research
- Adherence to Oral Therapy for Urgency Urinary Incontinence: Results from the Anticholinergic Versus Botox Comparison (ABC) Trial.
- Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial.
- Bladder cancer.
- Bladder cancer: chemohyperthermia for bladder cancer--clinically effective?
- Characterizing the Bladder's Response to Onabotulinum Toxin Type A Using a Rat Model.
- Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladder cancer during BCG shortage.
- Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence.
- Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis.
- Effects of intravesical prostaglandin E2 on bladder function are preserved in capsaicin-desensitized rats.
- Efficacy of intravesical ropivacaine injection on urinary symptoms following ureteral stenting: a randomized, controlled study.
- Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial.
- From Dog's Breakfast to Michelin Guide: Post-bacillus Calmette-Guérin Trials in Non-muscle-invasive Bladder Cancer.
- Heated Intravesical Chemotherapy: Biology and Clinical Utility.
- Hyperthermia and intravesical therapy: emerging one-two punch for bladder cancer?
- Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial.
- Intravesical capsaicin therapy: a review.
- Intravesical instillation of gentamicin sulfate: in vitro, rat, canine, and human studies.
- Intravesical liposome administration--a novel treatment for hyperactive bladder in the rat.
- Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
- Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity.
- Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
- Intravesical therapy use in the high risk patient: practice patterns in an equal access healthcare institution before and after national guidelines.
- LPS-sensory peptide communication in experimental cystitis.
- NCCN Guidelines Insights: Bladder Cancer, Version 5.2018.
- NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
- Nuclear factor kappa B mediates lipopolysaccharide-induced inflammation in the urinary bladder.
- Perioperative Intravesical Chemotherapy for Patients WithNon-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use.
- Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
- Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial.
- Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
- Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study.
- Strategies to enhance the efficacy of intravescical therapy for non-muscle invasive bladder cancer.
- Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
- The impact of the social construct of race on outcomes among bacille Calmette-Guérin-treated patients with high-risk non-muscle-invasive bladder cancer in an equal-access setting.
- The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review.
- The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor.
- The use of amphotericin B in nosocomial fungal infection.
- Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors.
- Treatment outcomes of overactive bladder with combined therapies of botulinum toxin injections and oral agents.
- Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls.
- Urodynamic and immunohistochemical evaluation of intravesical capsaicin delivery using thermosensitive hydrogel and liposomes.
- Urologic chronic pelvic pain syndrome.